The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Catalyst Pharmaceuticals Inc shares valued at $301,455 were sold by Tierney David S on Aug 21 ’24. At $20.10 per share, Tierney David S sold 15,000 shares. The insider’s holdings dropped to 348,874 shares worth approximately $6.94 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Miller Steve sold 150,000 shares, netting a total of over 3,052,900 in proceeds. Following the sale of shares at $20.35 each, the insider now holds 675,124 shares.
Before that, Tierney David S had added 15,000 shares to its account. In a trade valued at $301,450, the Director bought Catalyst Pharmaceuticals Inc shares for $20.10 each.
As published in their initiating research note from Citigroup on March 14, 2024, Catalyst Pharmaceuticals Inc [CPRX] has been a Buy and the price target has been revised to $27. Analysts at BofA Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early March. As of December 21, 2023, Oppenheimer has initiated its “an Outperform” rating for CPRX. Earlier on August 24, 2022, ROTH Capital downgraded its rating. Their new recommendation was “a Neutral” for CPRX stock which previously was a “a Buy”.
Analyzing CPRX Stock Performance
During the last five days, there has been a drop of approximately -0.35%. Over the course of the year, Catalyst Pharmaceuticals Inc shares have jumped approximately 18.26%. Shares of the company reached a 52-week high of $21.67 on 09/20/24 and a 52-week low of $13.12 on 02/08/24. A 50-day SMA is recorded $19.37, while a 200-day SMA reached $16.45. Nevertheless, trading volume fell to 0.57 million shares from 0.65 million shares the previous day.
Support And Resistance Levels for Catalyst Pharmaceuticals Inc (CPRX)
According to the 24-hour chart, there is a support level at 19.69, which, if violated, would cause prices to drop to 19.50. In the upper region, resistance lies at 20.04. The next price resistance is at 20.21. RSI (Relative Strength Index) is 49.42 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.25, which suggests the price will decrease in the coming days. Percent R is at 77.11%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
